Viewray Inc (NASDAQ:VRAY) was the recipient of some unusual options trading on Monday. Investors purchased 2,843 call options on the company. This represents an increase of approximately 2,634% compared to the average daily volume of 104 call options.

VRAY has been the subject of a number of recent analyst reports. BidaskClub upgraded Viewray from a “hold” rating to a “buy” rating in a research note on Tuesday, January 22nd. ValuEngine upgraded Viewray from a “hold” rating to a “buy” rating in a research note on Wednesday, January 16th. Guggenheim initiated coverage on Viewray in a research note on Tuesday, January 15th. They issued a “buy” rating and a $13.00 price objective for the company. B. Riley restated a “buy” rating and issued a $12.00 price objective (down previously from $13.75) on shares of Viewray in a research note on Monday, March 11th. Finally, Zacks Investment Research upgraded Viewray from a “hold” rating to a “buy” rating and set a $8.25 price objective for the company in a research note on Saturday, February 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $12.63.

Several large investors have recently added to or reduced their stakes in the business. American International Group Inc. raised its holdings in shares of Viewray by 3.9% in the 4th quarter. American International Group Inc. now owns 41,576 shares of the company’s stock valued at $252,000 after acquiring an additional 1,573 shares in the last quarter. Legal & General Group Plc raised its holdings in shares of Viewray by 20.8% in the 3rd quarter. Legal & General Group Plc now owns 9,719 shares of the company’s stock valued at $91,000 after acquiring an additional 1,676 shares in the last quarter. NumerixS Investment Technologies Inc raised its holdings in shares of Viewray by 90.6% in the 4th quarter. NumerixS Investment Technologies Inc now owns 6,100 shares of the company’s stock valued at $34,000 after acquiring an additional 2,900 shares in the last quarter. Pennsylvania Trust Co raised its holdings in shares of Viewray by 2.5% in the 1st quarter. Pennsylvania Trust Co now owns 129,441 shares of the company’s stock valued at $957,000 after acquiring an additional 3,100 shares in the last quarter. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of Viewray by 3.5% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 100,230 shares of the company’s stock valued at $938,000 after acquiring an additional 3,365 shares in the last quarter.

Shares of VRAY opened at $7.09 on Tuesday. The stock has a market cap of $677.66 million, a P/E ratio of -7.23 and a beta of 1.27. The company has a debt-to-equity ratio of 0.33, a quick ratio of 4.24 and a current ratio of 5.15. Viewray has a 52-week low of $4.86 and a 52-week high of $13.21.

Viewray (NASDAQ:VRAY) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.06. The business had revenue of $20.66 million for the quarter, compared to analysts’ expectations of $20.38 million. Viewray had a negative return on equity of 58.78% and a negative net margin of 94.36%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.38) EPS. As a group, research analysts expect that Viewray will post -0.82 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Traders Buy High Volume of Viewray Call Options (VRAY)” was reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.watchlistnews.com/traders-buy-high-volume-of-viewray-call-options-vray/2982179.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Featured Story: How Do You Calculate Return on Investment (ROI)?

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.